Kennedy Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-90,203
Closed -$374K 615
2025
Q2
$374K Buy
90,203
+62,979
+231% +$395K 0.01% 550
2025
Q1
$164K Sell
27,224
-35,826
-57% -$219K ﹤0.01% 629
2024
Q4
$326K Sell
63,050
-553,720
-90% -$2.18M 0.01% 647
2024
Q3
$1.84M Buy
616,770
+404,567
+191% +$1.1M 0.04% 525
2024
Q2
$632K Buy
+212,203
New +$1.75M 0.01% 626
2018
Q3
Sell
-15,204
Closed -$1.25M 772
2018
Q2
$1.25M Sell
15,204
-249
-2% -$15.2K 0.02% 650
2018
Q1
$553K Buy
+15,453
New +$599K 0.01% 692

Other funds holding VSTM

Kennedy Capital Management's VSTM Position: Q3 2025 in Review

Kennedy Capital Management sold out of Verastem (VSTM) in Q3 2025, closing a stake of 90,203 shares — an estimated $374K sold.

Kennedy Capital Management first reported a position in VSTM in Q1 2018 and held it in 7 quarters. The position peaked at $1.84M in Q3 2024. 118 funds tracked by Wall St. Rank hold VSTM as of Q3 2025.

  • Kennedy Capital Management reported no remaining Verastem position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 90,203 Verastem shares in Q3 2025, an estimated $374K.
  • Kennedy Capital Management first reported a position in Verastem in Q1 2018 and held it in 7 quarters.
  • Kennedy Capital Management's Verastem position peaked at $1.84M in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Verastem as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.